Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ER retention sequence binding	KDELR2 CEMIP KDELR1	6.65e-06	5	176	3	GO:0046923
GeneOntologyMolecularFunction	signal sequence binding	KDELR2 TNPO2 NUP98 CEMIP KDELR1	8.50e-05	51	176	5	GO:0005048
GeneOntologyMolecularFunction	KDEL sequence binding	KDELR2 KDELR1	2.30e-04	3	176	2	GO:0005046
GeneOntologyCellularComponent	membrane attack complex	C5 C6 C9	2.04e-05	7	177	3	GO:0005579
GeneOntologyCellularComponent	actin cytoskeleton	MYH6 MYH11 PDCD6IP MYH13 IQGAP2 SPTBN1 SRC ANKRD26 DST GYS2 DIAPH1 PXN CTTN CDH2 HCK HCLS1	3.31e-05	576	177	16	GO:0015629
GeneOntologyCellularComponent	pore complex	C5 C6 C9 VDAC1	6.42e-05	26	177	4	GO:0046930
GeneOntologyCellularComponent	muscle myosin complex	MYH6 MYH11 MYH13	3.08e-04	16	177	3	GO:0005859
GeneOntologyCellularComponent	cell leading edge	IQGAP2 TRPM7 SPTBN1 SRC DYSF FAT1 DST SYNE2 MKLN1 DIAPH1 PXN CTTN CDH2	3.49e-04	500	177	13	GO:0031252
GeneOntologyCellularComponent	postsynaptic specialization	FMR1 SPTBN1 SRC RTN3 SYNDIG1 SLITRK3 GRM1 DICER1 DST SHANK2 MKLN1 CDH2 VDAC1	3.69e-04	503	177	13	GO:0099572
GeneOntologyCellularComponent	cell-substrate junction	NRAP PDCD6IP ANXA6 SRC FAT1 DST HMCN1 SYNE2 PXN CTTN CDH2 HCK	4.10e-04	443	177	12	GO:0030055
GeneOntologyCellularComponent	supramolecular fiber	MYH6 MYH11 NRAP MYH13 IQGAP2 NDE1 SPTBN1 MDM1 SRC EML6 CASQ2 DYSF DST SHANK2 DNAH17 SYNE2 TPX2 DIAPH1 TNK2 CTTN HCK HCLS1	4.19e-04	1179	177	22	GO:0099512
GeneOntologyCellularComponent	dendritic filopodium	FMR1 SRC	4.23e-04	4	177	2	GO:1902737
GeneOntologyCellularComponent	supramolecular polymer	MYH6 MYH11 NRAP MYH13 IQGAP2 NDE1 SPTBN1 MDM1 SRC EML6 CASQ2 DYSF DST SHANK2 DNAH17 SYNE2 TPX2 DIAPH1 TNK2 CTTN HCK HCLS1	4.59e-04	1187	177	22	GO:0099081
GeneOntologyCellularComponent	cell-cell junction	MPP3 AHI1 NRAP PDCD6IP ANXA6 PLEKHG4B FRMD4A FAT1 DST HMCN1 PXN TNK2 CDH2 CDH9	5.26e-04	591	177	14	GO:0005911
GeneOntologyCellularComponent	neuron to neuron synapse	FMR1 SPTBN1 RTN3 SYNDIG1 SLITRK3 GRM1 DICER1 DST SHANK2 MKLN1 CDH2 CDH9 VDAC1	5.33e-04	523	177	13	GO:0098984
GeneOntologyCellularComponent	postsynaptic membrane	FMR1 SYNDIG1 SLITRK3 GRM1 ADRB2 SHANK2 MKLN1 GNAO1 CDH2 CDH9 VDAC1	6.97e-04	405	177	11	GO:0045211
GeneOntologyCellularComponent	centrosome	IFT140 AHI1 PDCD6IP NDE1 MDM1 ANKRD26 NFS1 DYSF MYOF CD86 KIAA1217 CEP83 SNX10 ERCC6L2 DIAPH1 NUP93	8.75e-04	770	177	16	GO:0005813
GeneOntologyCellularComponent	muscle tendon junction	NRAP HMCN1	1.05e-03	6	177	2	GO:0005927
GeneOntologyCellularComponent	postsynapse	FMR1 SPTBN1 SRC RTN3 SYNDIG1 SLITRK3 GRM1 ZZEF1 DICER1 ADRB2 DST SHANK2 MKLN1 TNK2 GNAO1 CTTN CDH2 CDH9 VDAC1	1.05e-03	1018	177	19	GO:0098794
GeneOntologyCellularComponent	membrane microdomain	SRC FAS DYSF NFAM1 MYOF ADRB2 FCER1A CDH2 HCK VDAC1	1.11e-03	364	177	10	GO:0098857
GeneOntologyCellularComponent	cortical actin cytoskeleton	SPTBN1 GYS2 CTTN CDH2 HCLS1	1.17e-03	93	177	5	GO:0030864
GeneOntologyCellularComponent	myosin filament	MYH6 MYH11 MYH13	1.20e-03	25	177	3	GO:0032982
GeneOntologyCellularComponent	cell cortex	IQGAP2 SPTBN1 DST HMCN1 GYS2 MKLN1 PXN CTTN CDH2 HCLS1	1.29e-03	371	177	10	GO:0005938
GeneOntologyCellularComponent	mitotic cohesin complex	STAG1 SGO2	1.46e-03	7	177	2	GO:0030892
GeneOntologyCellularComponent	anchoring junction	MPP3 AHI1 NRAP PDCD6IP ANXA6 SRC PLEKHG4B FRMD4A FAT1 DST HMCN1 SYNE2 PXN TNK2 CTTN CDH2 CDH9 HCK	1.62e-03	976	177	18	GO:0070161
GeneOntologyCellularComponent	postsynaptic density	FMR1 SPTBN1 RTN3 SYNDIG1 SLITRK3 GRM1 DICER1 DST SHANK2 CDH2 VDAC1	1.65e-03	451	177	11	GO:0014069
GeneOntologyCellularComponent	myosin II complex	MYH6 MYH11 MYH13	1.67e-03	28	177	3	GO:0016460
GeneOntologyCellularComponent	microtubule organizing center	IFT140 AHI1 PDCD6IP NDE1 MDM1 ANKRD26 PTPN23 NFS1 DYSF MYOF CD86 KIAA1217 CEP83 SNX10 ERCC6L2 DIAPH1 NUP93	2.12e-03	919	177	17	GO:0005815
GeneOntologyCellularComponent	adherens junction	MPP3 AHI1 FRMD4A HMCN1 TNK2 CDH2 CDH9	2.24e-03	212	177	7	GO:0005912
GeneOntologyCellularComponent	asymmetric synapse	FMR1 SPTBN1 RTN3 SYNDIG1 SLITRK3 GRM1 DICER1 DST SHANK2 CDH2 VDAC1	2.56e-03	477	177	11	GO:0032279
GeneOntologyCellularComponent	intercalated disc	NRAP ANXA6 DST CDH2	2.65e-03	68	177	4	GO:0014704
Domain	ALIX_LYPXL_bnd	PDCD6IP PTPN23	8.53e-05	2	173	2	PF13949
Domain	CORTACTIN	CTTN HCLS1	8.53e-05	2	173	2	PS51090
Domain	ALIX_V_dom	PDCD6IP PTPN23	8.53e-05	2	173	2	IPR025304
Domain	HS1_rep	CTTN HCLS1	8.53e-05	2	173	2	PF02218
Domain	Hs1_Cortactin	CTTN HCLS1	8.53e-05	2	173	2	IPR003134
Domain	SH3	MPP3 AHI1 SRC DST SHANK2 TNK2 CTTN HCK HCLS1	1.89e-04	216	173	9	PS50002
Domain	SH3_domain	MPP3 AHI1 SRC DST SHANK2 TNK2 CTTN HCK HCLS1	2.16e-04	220	173	9	IPR001452
Domain	IG_MHC	RAET1G CD86 ULBP2 RAET1L SIGLEC11	2.33e-04	60	173	5	PS00290
Domain	ER_ret_rcpt	KDELR2 KDELR1	2.54e-04	3	173	2	IPR000133
Domain	FerA	DYSF MYOF	2.54e-04	3	173	2	SM01200
Domain	Ferlin_A-domain	DYSF MYOF	2.54e-04	3	173	2	IPR012560
Domain	ER_lumen_recept	KDELR2 KDELR1	2.54e-04	3	173	2	PF00810
Domain	ER_LUMEN_RECEPTOR_1	KDELR2 KDELR1	2.54e-04	3	173	2	PS00951
Domain	ER_LUMEN_RECEPTOR_2	KDELR2 KDELR1	2.54e-04	3	173	2	PS00952
Domain	FerA	DYSF MYOF	2.54e-04	3	173	2	PF08165
Domain	TSP_1	ADAMTS2 HMCN1 ADAMTS6 C6 C9	2.93e-04	63	173	5	PF00090
Domain	Myosin_N	MYH6 MYH11 MYH13	3.27e-04	15	173	3	PF02736
Domain	Myosin_N	MYH6 MYH11 MYH13	3.27e-04	15	173	3	IPR004009
Domain	TSP1	ADAMTS2 HMCN1 ADAMTS6 C6 C9	3.39e-04	65	173	5	SM00209
Domain	TSP1_rpt	ADAMTS2 HMCN1 ADAMTS6 C6 C9	3.39e-04	65	173	5	IPR000884
Domain	TSP1	ADAMTS2 HMCN1 ADAMTS6 C6 C9	3.39e-04	65	173	5	PS50092
Domain	CH	CFAP47 IQGAP2 SPTBN1 DST SYNE2	4.79e-04	70	173	5	PF00307
Domain	DysFC	DYSF MYOF	5.06e-04	4	173	2	SM00694
Domain	DysFN	DYSF MYOF	5.06e-04	4	173	2	SM00693
Domain	Peroxin/Ferlin	DYSF MYOF	5.06e-04	4	173	2	IPR006614
Domain	-	CFAP47 IQGAP2 SPTBN1 DST SYNE2	5.11e-04	71	173	5	1.10.418.10
Domain	Myosin_tail_1	MYH6 MYH11 MYH13	5.75e-04	18	173	3	PF01576
Domain	Myosin_tail	MYH6 MYH11 MYH13	5.75e-04	18	173	3	IPR002928
Domain	CH	CFAP47 IQGAP2 SPTBN1 DST SYNE2	5.81e-04	73	173	5	PS50021
Domain	CH-domain	CFAP47 IQGAP2 SPTBN1 DST SYNE2	6.58e-04	75	173	5	IPR001715
Domain	Myosin-like_IQ_dom	MYH6 MYH11 MYH13	6.79e-04	19	173	3	IPR027401
Domain	-	MYH6 MYH11 MYH13	6.79e-04	19	173	3	4.10.270.10
Domain	FerI	DYSF MYOF	8.38e-04	5	173	2	SM01202
Domain	FerB	DYSF MYOF	8.38e-04	5	173	2	SM01201
Domain	Ferlin_B-domain	DYSF MYOF	8.38e-04	5	173	2	IPR012561
Domain	Ferlin_C	DYSF MYOF	8.38e-04	5	173	2	PF16165
Domain	Ferlin_C	DYSF MYOF	8.38e-04	5	173	2	IPR032362
Domain	BRO1	PDCD6IP PTPN23	8.38e-04	5	173	2	PF03097
Domain	FerIin_dom	DYSF MYOF	8.38e-04	5	173	2	IPR012968
Domain	FerI	DYSF MYOF	8.38e-04	5	173	2	PF08151
Domain	FerB	DYSF MYOF	8.38e-04	5	173	2	PF08150
Domain	BRO1_dom	PDCD6IP PTPN23	8.38e-04	5	173	2	IPR004328
Domain	BRO1	PDCD6IP PTPN23	8.38e-04	5	173	2	SM01041
Domain	BRO1	PDCD6IP PTPN23	8.38e-04	5	173	2	PS51180
Domain	-	PDCD6IP PTPN23	8.38e-04	5	173	2	1.25.40.280
Domain	SH3_1	AHI1 SRC DST TNK2 CTTN HCK HCLS1	8.52e-04	164	173	7	PF00018
Domain	MHC_I	RAET1G ULBP2 RAET1L	9.19e-04	21	173	3	PF00129
Domain	MHC_I_a_a1/a2	RAET1G ULBP2 RAET1L	9.19e-04	21	173	3	IPR001039
Domain	SH3	MPP3 AHI1 SRC SHANK2 TNK2 CTTN HCK HCLS1	9.30e-04	216	173	8	SM00326
Domain	Spectrin	SPTBN1 DST SYNE2	1.21e-03	23	173	3	PF00435
Domain	ACTININ_2	SPTBN1 DST SYNE2	1.21e-03	23	173	3	PS00020
Domain	ACTININ_1	SPTBN1 DST SYNE2	1.21e-03	23	173	3	PS00019
Domain	Actinin_actin-bd_CS	SPTBN1 DST SYNE2	1.21e-03	23	173	3	IPR001589
Domain	MACPF_CS	C6 C9	1.25e-03	6	173	2	IPR020863
Domain	-	CUBN ZZEF1 CSMD3 BMP1	1.36e-03	52	173	4	2.60.120.290
Domain	-	RAET1G ULBP2 RAET1L	1.37e-03	24	173	3	3.30.500.10
Domain	MHC_I-like_Ag-recog	RAET1G ULBP2 RAET1L	1.37e-03	24	173	3	IPR011161
Domain	MACPF_2	C6 C9	1.74e-03	7	173	2	PS51412
Domain	MACPF_1	C6 C9	1.74e-03	7	173	2	PS00279
Domain	CUB_dom	CUBN ZZEF1 CSMD3 BMP1	1.92e-03	57	173	4	IPR000859
Domain	Ig/MHC_CS	RAET1G CD86 ULBP2 SIGLEC11	2.04e-03	58	173	4	IPR003006
Domain	Spectrin_repeat	SPTBN1 DST SYNE2	2.39e-03	29	173	3	IPR002017
Pathway	BIOCARTA_ALTERNATIVE_PATHWAY	CFB C5 C6 C9	8.14e-07	9	129	4	M22072
Pathway	KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION	C5 C6 C9	2.55e-05	7	129	3	M47873
Pathway	BIOCARTA_COMP_PATHWAY	CFB C5 C6 C9	2.89e-05	20	129	4	M917
Pathway	BIOCARTA_ALTERNATIVE_PATHWAY	C5 C6 C9	4.05e-05	8	129	3	MM1582
Pathway	REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT	C5 C6 C9	4.05e-05	8	129	3	MM14656
Pathway	REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT	C5 C6 C9	4.05e-05	8	129	3	M27006
Pathway	WP_COMPLEMENT_ACTIVATION	CFB C5 C6 C9	4.31e-05	22	129	4	M39502
Pathway	BIOCARTA_LECTIN_PATHWAY	C5 C6 C9	1.17e-04	11	129	3	MM1430
Pathway	BIOCARTA_CLASSIC_PATHWAY	C5 C6 C9	1.55e-04	12	129	3	MM1368
Pathway	WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY	C5 C6 C9	1.55e-04	12	129	3	M48316
Pathway	BIOCARTA_LECTIN_PATHWAY	C5 C6 C9	2.00e-04	13	129	3	M4732
Pathway	PID_ARF6_PATHWAY	SRC ADRB2 GNA14 PXN	2.81e-04	35	129	4	M86
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	MYH11 IQGAP2 NDE1 DOCK11 SPTBN1 SRC NUP98 ANKRD26 SLITRK3 PLEKHG4B ARHGDIB DST DIAPH1 SGO2 ARHGAP28 CTTN PCDH7	3.00e-04	720	129	17	M41838
Pathway	BIOCARTA_CLASSIC_PATHWAY	C5 C6 C9	3.14e-04	15	129	3	M7146
Pathway	WP_G13_SIGNALING	IQGAP2 ARHGDIB DIAPH1 TNK2	3.88e-04	38	129	4	M39606
Pathway	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	CFB SERPINA1 C5 C6 C9	4.18e-04	69	129	5	M16894
Pathway	WP_G13_SIGNALING_PATHWAY	IQGAP2 ARHGDIB DIAPH1 TNK2	4.30e-04	39	129	4	MM15898
Pathway	WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY	C5 C6 C9	4.63e-04	17	129	3	MM15944
Pathway	BIOCARTA_COMP_PATHWAY	C5 C6 C9	4.63e-04	17	129	3	MM1369
Pathway	REACTOME_SMOOTH_MUSCLE_CONTRACTION	MYH11 ANXA6 DYSF PXN	6.27e-04	43	129	4	M1429
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	UTP6 TPR FMR1 POLR1A PDCD6IP ANXA6 SPTBN1 NUP98 DICER1 IGF2BP3 DST SYNE2 PDCD11 NUP93 COIL ZBTB11 ZNF512 VDAC1	1.01e-08	653	180	18	22586326
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	CMBL PDCD6IP MYH13 IQGAP2 ANXA6 SPTBN1 S100A14 SRC PTPN23 CP NAA50 CUBN DYSF STAMBP ARHGDIB MYOF SERPINA1 FAT1 C5 C9 VDAC1	8.08e-08	1016	180	21	19056867
Pubmed	Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis.	SRC PXN CTTN HCK	8.57e-08	9	180	4	16636290
Pubmed	Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.	RAET1G ULBP2 RAET1L	1.36e-07	3	180	3	25212604
Pubmed	The functional interactome landscape of the human histone deacetylase family.	UTP6 TPR STAG1 MDM1 NUP98 DICER1 IGF2BP3 SYNE2 TPX2 PDCD11 NUP93	3.67e-07	289	180	11	23752268
Pubmed	Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.	SRC TNK2 CTTN HCK HCLS1	4.51e-07	30	180	5	12522270
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	FMR1 PDCD6IP NDE1 SPTBN1 PEX1 PTPN23 APOB FAS MED24 MYOF IGF2BP3 SYNE2 TPX2 SHPRH NUP93 HCLS1 VDAC1	4.56e-07	754	180	17	35906200
Pubmed	Cross-Linking Mass Spectrometry Uncovers Interactions Between High-Density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein.	MYH6 MYH11 CP APOB CFB MYOF C6	5.35e-07	92	180	7	37343697
Pubmed	Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms.	RAET1G ULBP2 RAET1L	5.43e-07	4	180	3	20166740
Pubmed	Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.	RAET1G ULBP2 RAET1L	5.43e-07	4	180	3	12421908
Pubmed	NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.	RAET1G ULBP2 RAET1L	5.43e-07	4	180	3	12756263
Pubmed	Murine NKG2D ligands: "double, double toil and trouble".	RAET1G ULBP2 RAET1L	5.43e-07	4	180	3	19081632
Pubmed	Exposure to the complement C5b-9 complex sensitizes 661W photoreceptor cells to both apoptosis and necroptosis.	C5 C6 C9	5.43e-07	4	180	3	25735751
Pubmed	Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules.	RAET1G ULBP2 RAET1L	5.43e-07	4	180	3	8882725
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	MYH11 PDCD6IP ANXA6 CP APOB MINPP1 CUBN DYSF CFB STAMBP MYOF SERPINA1 SERPINI2 GNA14 HMCN1 C5 C6 C9 VDAC1 STK25	8.12e-07	1070	180	20	23533145
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	KLHL6 TPR AHI1 PDCD6IP IQGAP2 HOPX ZNF652 SPTBN1 PEG3 PEX1 PTPN23 APOB CUBN MED24 COQ8A MKLN1 DIAPH1 ZMYM1 PARP12 STK25	9.91e-07	1084	180	20	11544199
Pubmed	MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation.	RAET1G ULBP2 RAET1L	1.35e-06	5	180	3	24572784
Pubmed	Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain.	RAET1G ULBP2 RAET1L	1.35e-06	5	180	3	8982867
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	AMPD1 FMR1 NRAP SPTBN1 PEG3 ANKRD26 DYSF ARHGDIB DST SYNE2 MKLN1 PXN HSPB8	2.18e-06	497	180	13	23414517
Pubmed	Nucleoporins as components of the nuclear pore complex core structure and Tpr as the architectural element of the nuclear basket.	TPR NUP98 NUP93	2.70e-06	6	180	3	15229283
Pubmed	Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D.	RAET1G ULBP2 RAET1L	2.70e-06	6	180	3	11825567
Pubmed	Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.	RAET1G ULBP2 RAET1L	2.70e-06	6	180	3	10894171
Pubmed	Ligands for murine NKG2D display heterogeneous binding behavior.	RAET1G ULBP2 RAET1L	2.70e-06	6	180	3	11857333
Pubmed	Single nucleotide polymorphism analysis of the NKG2D ligand cluster on the long arm of chromosome 6: Extensive polymorphisms and evidence of diversity between human populations.	RAET1G ULBP2 RAET1L	2.70e-06	6	180	3	20219610
Pubmed	Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9.	C5 C6 C9	2.70e-06	6	180	3	22832194
Pubmed	The NKG2D ligands RAE-1δ and RAE-1ε differ with respect to their receptor affinity, expression profiles and transcriptional regulation.	RAET1G ULBP2 RAET1L	2.70e-06	6	180	3	20976056
Pubmed	Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in northeastern Thais.	RAET1G ULBP2 RAET1L	2.70e-06	6	180	3	19688209
Pubmed	Biochemical properties of the Cdc42-associated tyrosine kinase ACK1. Substrate specificity, authphosphorylation, and interaction with Hck.	SRC TNK2 HCK	2.70e-06	6	180	3	14506255
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	TPR MYH6 MYH11 SPTBN1 KIAA1217 TPX2 HSPB8	2.88e-06	118	180	7	30979931
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	TPR FMR1 MYH13 TEX15 TERT IGF2BP3 DST TPX2 CTTN	3.99e-06	234	180	9	36243803
Pubmed	The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.	RAET1G ULBP2 RAET1L	4.70e-06	7	180	3	16831899
Pubmed	Stress-regulated targeting of the NKG2D ligand Mult1 by a membrane-associated RING-CH family E3 ligase.	RAET1G ULBP2 RAET1L	4.70e-06	7	180	3	20870941
Pubmed	Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma.	RAET1G ULBP2 RAET1L	4.70e-06	7	180	3	26151313
Pubmed	NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis.	RAET1G ULBP2 RAET1L	4.70e-06	7	180	3	30787931
Pubmed	Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.	RAET1G ULBP2 RAET1L	4.70e-06	7	180	3	12370332
Pubmed	Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.	C5 C6 C9	4.70e-06	7	180	3	19864026
Pubmed	Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation.	C5 C6 C9	4.70e-06	7	180	3	30910380
Pubmed	CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers.	C5 C6 C9	4.70e-06	7	180	3	30552328
Pubmed	NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.	RAET1G ULBP2 RAET1L	4.70e-06	7	180	3	25583577
Pubmed	Direct interaction with nup153 mediates binding of Tpr to the periphery of the nuclear pore complex.	TPR NUP98 NUP93	4.70e-06	7	180	3	12802065
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	KLHL6 MYH6 POLR1A MYH13 SRC PEX1 GSKIP NFS1 DICER1 MYOF DST TPX2 PXN TNK2 CTTN HCK STK25	5.72e-06	910	180	17	36736316
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	KDELR2 MYH6 MYH11 MYH13 STAG1 IQGAP2 ABCB5 SPTBN1 EML6 NUP98 ANKRD26 ANKRD30B APOB DST SHANK2 SYNE2 CEP83 KDELR1 GNAO1 CTTN ZBTB11 HCLS1	6.09e-06	1442	180	22	35575683
Pubmed	A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.	RAET1G ULBP2 RAET1L	7.49e-06	8	180	3	12645935
Pubmed	Molecular organization and function of the complement system.	CFB C5 C6	7.49e-06	8	180	3	3052276
Pubmed	The Cdc42-associated kinase ACK1 is not autoinhibited but requires Src for activation.	SRC TNK2 HCK	7.49e-06	8	180	3	21309750
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	EPC2 ANKRD26 CP RLF MED24 IGF2BP3 DST TPX2 SHPRH DIAPH1 SGO2 GNAO1 ZNF512 VDAC1	7.54e-06	645	180	14	25281560
Pubmed	A human MAP kinase interactome.	TPR IFT140 MYH11 PDCD6IP SPTBN1 SRC NUP98 PTPN23 STAMBP DST TNK2 HCK	9.68e-06	486	180	12	20936779
Pubmed	Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells.	C5 C6 C9	1.12e-05	9	180	3	19162005
Pubmed	Independent SH2-binding sites mediate interaction of Dok-related protein with RasGTPase-activating protein and Nck.	SRC HCK HCLS1	1.12e-05	9	180	3	10428862
Pubmed	Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor.	RAET1G ULBP2 RAET1L	1.12e-05	9	180	3	14764662
Pubmed	Gut microbiota regulates NKG2D ligand expression on intestinal epithelial cells.	RAET1G ULBP2 RAET1L	1.12e-05	9	180	3	23136011
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	POLR1A MYH13 DOCK11 SPTBN1 DYSF TTC6 SERPINA1 PTPRB ERCC6L2 SHPRH CTTN ARMH3	1.21e-05	497	180	12	36774506
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	CMBL TPR STAG1 IQGAP2 TNPO2 PTPN23 IGF2BP3 DST SYNE2 PXN GNAO1 CTTN	1.23e-05	498	180	12	36634849
Pubmed	Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.	SRC CTTN HCK HCLS1	1.29e-05	28	180	4	18067320
Pubmed	Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes.	SRC CTTN HCK	1.59e-05	10	180	3	18155796
Pubmed	A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3.	RAET1G ULBP2 RAET1L	1.59e-05	10	180	3	11827464
Pubmed	Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.	CFB C5 C6 C9	1.96e-05	31	180	4	19344414
Pubmed	Autophosphorylation-independent and -dependent functions of focal adhesion kinase during development.	SRC PXN CTTN	2.18e-05	11	180	3	19776009
Pubmed	Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles.	RAET1G ULBP2 RAET1L	2.18e-05	11	180	3	26656785
Pubmed	Characterization of molecules binding to the 70K N-terminal region of fibronectin by IFAST purification coupled with mass spectrometry.	CFB SERPINA1 C6 C9	2.23e-05	32	180	4	23750785
Pubmed	An investigation into the human serum "interactome".	PEG3 CP DICER1 CFB IGDCC4 RLF SGO2	2.30e-05	162	180	7	15174051
Pubmed	Absence of functional alternative complement pathway alleviates lupus cerebritis.	FAS CFB	2.66e-05	2	180	2	17523212
Pubmed	Complete primary structure and functional characterization of the sixth component of the human complement system. Identification of the C5b-binding domain in complement C6.	C5 C6	2.66e-05	2	180	2	2808363
Pubmed	Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.	FAS CFB	2.66e-05	2	180	2	10623824
Pubmed	Bpag1 localization to actin filaments and to the nucleus is regulated by its N-terminus.	DST PXN	2.66e-05	2	180	2	14576348
Pubmed	Phosphorylation of FMRP inhibits association with Dicer.	FMR1 DICER1	2.66e-05	2	180	2	19155329
Pubmed	Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus.	FAS SERPINA1	2.66e-05	2	180	2	27232337
Pubmed	Neutrophils activated by membrane attack complexes increase the permeability of melanoma blood vessels.	C5 C6	2.66e-05	2	180	2	35960843
Pubmed	pp60Src mediates insulin-stimulated sequestration of the beta(2)-adrenergic receptor: insulin stimulates pp60Src phosphorylation and activation.	SRC ADRB2	2.66e-05	2	180	2	12429837
Pubmed	Pathways of metastasis suppression in bladder cancer.	SRC ARHGDIB	2.66e-05	2	180	2	20013033
Pubmed	The nucleoporin Nup98 associates with the intranuclear filamentous protein network of TPR.	TPR NUP98	2.66e-05	2	180	2	11248057
Pubmed	Stimulation of the B cell receptor, CD86 (B7-2), and the beta 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell.	ADRB2 CD86	2.66e-05	2	180	2	10878340
Pubmed	Solution structure of the inner DysF domain of myoferlin and implications for limb girdle muscular dystrophy type 2b.	DYSF MYOF	2.66e-05	2	180	2	18495154
Pubmed	Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein.	SRC HCK	2.66e-05	2	180	2	18042718
Pubmed	Comparative genome analysis of cortactin and HS1: the significance of the F-actin binding repeat domain.	CTTN HCLS1	2.66e-05	2	180	2	15710041
Pubmed	Selective regulation of mature IgG1 transcription by CD86 and beta 2-adrenergic receptor stimulation.	ADRB2 CD86	2.66e-05	2	180	2	12734361
Pubmed	Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.	FAS CFB	2.66e-05	2	180	2	36076550
Pubmed	Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas.	TERT CDH2	2.66e-05	2	180	2	27886397
Pubmed	Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains.	DYSF MYOF	2.66e-05	2	180	2	11959863
Pubmed	Cross talk between receptor guanylyl cyclase C and c-src tyrosine kinase regulates colon cancer cell cytostasis.	SRC GUCY2C	2.66e-05	2	180	2	19620276
Pubmed	Loss of dysferlin or myoferlin results in differential defects in excitation-contraction coupling in mouse skeletal muscle.	DYSF MYOF	2.66e-05	2	180	2	34354129
Pubmed	Identification and biophysical assessment of the molecular recognition mechanisms between the human haemopoietic cell kinase Src homology domain 3 and ALG-2-interacting protein X.	PDCD6IP HCK	2.66e-05	2	180	2	20670214
Pubmed	Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis.	FAS TERT	2.66e-05	2	180	2	19272297
Pubmed	Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.	SRC ARHGDIB	2.66e-05	2	180	2	19321744
Pubmed	Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707.	SRC TERT	2.66e-05	2	180	2	12808100
Pubmed	Caspases target only two architectural components within the core structure of the nuclear pore complex.	NUP98 NUP93	2.66e-05	2	180	2	16286466
Pubmed	Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice.	C5 C9	2.66e-05	2	180	2	27444648
Pubmed	Genetic Variability in the Iron Homeostasis Pathway and Patient Outcomes After Aneurysmal Subarachnoid Hemorrhage.	CP CUBN	2.66e-05	2	180	2	32246437
Pubmed	Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis.	TRPM7 FAS	2.66e-05	2	180	2	22698280
Pubmed	Extracellular glutamate exposure facilitates group I mGluR-mediated epileptogenesis in the hippocampus.	FMR1 GRM1	2.66e-05	2	180	2	25568123
Pubmed	A Golgi-based KDELR-dependent signalling pathway controls extracellular matrix degradation.	KDELR2 KDELR1	2.66e-05	2	180	2	25682866
Pubmed	Identification of a protein, SPY75, with repetitive helix-turn-helix motifs and an SH3 domain as a major substrate for protein tyrosine kinase(s) activated by Fc epsilon RI cross-linking.	FCER1A HCLS1	2.66e-05	2	180	2	7506729
Pubmed	Structural Basis for the Distinct Membrane Binding Activity of the Homologous C2A Domains of Myoferlin and Dysferlin.	DYSF MYOF	2.66e-05	2	180	2	31004665
Pubmed	Uncoupling protein-2 attenuates glucose-stimulated insulin secretion in INS-1E insulinoma cells by lowering mitochondrial reactive oxygen species.	FAS UCP2	2.66e-05	2	180	2	21172424
Pubmed	Development of novel microarray methodology for the study of mutations in the SERPINA1 and ADRB2 genes--their association with Obstructive Pulmonary Disease and Disseminated Bronchiectasis in Greek patients.	SERPINA1 ADRB2	2.66e-05	2	180	2	19747908
Pubmed	Support for involvement of the AHI1 locus in schizophrenia.	AHI1-DT AHI1	2.66e-05	2	180	2	17473831
Pubmed	B cell receptor- and beta 2-adrenergic receptor-induced regulation of B7-2 (CD86) expression in B cells.	ADRB2 CD86	2.66e-05	2	180	2	12055247
Pubmed	While dysferlin and myoferlin are coexpressed in the human placenta, only dysferlin expression is responsive to trophoblast fusion in model systems.	DYSF MYOF	2.66e-05	2	180	2	19228595
Pubmed	AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia.	AHI1-DT AHI1	2.66e-05	2	180	2	16773125
Pubmed	KDEL receptor regulates secretion by lysosome relocation- and autophagy-dependent modulation of lipid-droplet turnover.	KDELR2 KDELR1	2.66e-05	2	180	2	30760704
Interaction	ANKRD1 interactions	CASQ2 DYSF ARHGDIB DST CDCA7L	4.01e-06	28	176	5	int:ANKRD1
Interaction	SNCA interactions	CMBL TPR FMR1 STAG1 IQGAP2 ANXA6 SPTBN1 SRC PTPN23 STAMBP IGF2BP3 ADRB2 DST SYNE2 PXN GNAO1 CTTN HSPB8 HCLS1 VDAC1	4.74e-06	716	176	20	int:SNCA
GeneFamily	Complement system\|Sushi domain containing	CFB C5 C6 C9	9.22e-05	36	120	4	492
GeneFamily	Myosin heavy chains	MYH6 MYH11 MYH13	1.22e-04	15	120	3	1098
GeneFamily	Ferlin family	DYSF MYOF	6.44e-04	6	120	2	828
GeneFamily	Nucleoporins	TPR NUP98 NUP93	1.23e-03	32	120	3	1051
Coexpression	WHITFIELD_CELL_CYCLE_G2_M	AHI1 NDE1 SPTBN1 NUP98 ARHGDIB TPX2 SGO2 ZMYM1 C6	9.80e-06	198	180	9	M2077
Coexpression	GSE369_SOCS3_KO_VS_WT_LIVER_DN	KLHL6 CCDC125 EPC2 NDE1 SPTBN1 GSKIP PAM16 ARHGDIB CCDC82	1.06e-05	200	180	9	M5963
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	FMR1 IQGAP2 ADAMTS2 ANXA6 PEG3 CASQ2 CPED1 IGDCC4 MYOF IGF2BP3 FAT1 TENM4 GNA14 HMCN1 KIAA1217 SYNE2 TPX2 CTTN HSPB8	2.19e-05	768	176	19	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	UTP6 MYH6 RBM44 POLR1A TRPM7 DOCK11 ANXA6 SPTBN1 PEG3 HEMGN RLF RGN SERPINA1 TENM4 KIAA1217 RHEBL1 SYNE2 CTTN CDH2	4.23e-05	806	176	19	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_200	MYH11 ANXA6 SPTBN1 S100A14 CP RGN TINAG SYNE2	5.08e-05	157	176	8	gudmap_developingGonad_P2_epididymis_200
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	TRPM7 DOCK11 ANXA6 SPTBN1 RGN SERPINA1 TENM4 KIAA1217 SYNE2 CDH2	6.31e-05	259	176	10	gudmap_developingGonad_e12.5_epididymis_k3_1000
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYH13 EPHA6 TDRD9 PEG3 APOB DYSF CSMD3 NFAM1 CFB SERPINA1 HCK	2.57e-10	184	180	11	7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MPP3 MYH6 PDE1C NRAP CASQ2 ANO5 SYNDIG1 CPED1 CDH2 PCDH7	3.66e-09	181	180	10	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MPP3 MYH6 PDE1C NRAP CASQ2 ANO5 SYNDIG1 CPED1 CDH2 PCDH7	4.28e-09	184	180	10	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MPP3 MYH6 PDE1C NRAP CASQ2 ANO5 SYNDIG1 CPED1 CDH2 PCDH7	4.51e-09	185	180	10	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	MPP3 NRAP HOPX CASQ2 SYNDIG1 CPED1 KIAA1217 DIAPH1 CDH2 PCDH7	5.54e-09	189	180	10	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	(2)_Dendritic_Cells\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CPED1 ARHGDIB SERPINA1 FCER1A CD86 UCP2 SNX10 GNAO1 HCK HCLS1	5.83e-09	190	180	10	5163a5be95fb6c2609bfa3d69166af172f74e724
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	MPP3 NRAP HOPX CASQ2 SYNDIG1 CPED1 FAT1 DIAPH1 CDH2 PCDH7	5.83e-09	190	180	10	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	MPP3 MYH6 PDE1C NRAP CASQ2 ANO5 SYNDIG1 CPED1 CDH2 PCDH7	6.78e-09	193	180	10	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	MPP3 MYH6 PDE1C NRAP CASQ2 ANO5 CPED1 DST CDH2 PCDH7	7.48e-09	195	180	10	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH6 PDE1C NRAP CASQ2 ANO5 SYNDIG1 CPED1 CDH2 PCDH7	3.26e-08	170	180	9	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	MPP3 MYH6 NRAP TRPM7 CASQ2 ANO5 CPED1 CDH2 PCDH7	9.26e-08	192	180	9	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	(2)_MNPs\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ARHGDIB SERPINA1 FCER1A CD86 UCP2 SNX10 GNAO1 HCK HCLS1	1.01e-07	194	180	9	9cd64e325ec233da82c463b09262efe93d2a92ee
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	MPP3 PDE1C NRAP CASQ2 ANO5 SYNDIG1 CPED1 CDH2 PCDH7	1.06e-07	195	180	9	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	Fetal_29-31_weeks-Immune\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KLHL6 IQGAP2 DOCK11 ARHGDIB CD86 UCP2 SNX10 HCK HCLS1	1.20e-07	198	180	9	5dff131356b8c22743bd27b2b21f86ee6e4a0a0d
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE1C MYH11 CASQ2 SLITRK3 DYSF CPED1 ADAMTS6 PCDH7 HSPB8	1.20e-07	198	180	9	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE1C MYH11 CASQ2 SLITRK3 DYSF CPED1 ADAMTS6 PCDH7 HSPB8	1.20e-07	198	180	9	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_interstitial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	B3GNTL1 NFAM1 ARHGDIB SERPINA1 RHEBL1 UCP2 SNX10 HCK HCLS1	1.26e-07	199	180	9	4b6d49b96bfcd6604b082bab620ae03276520885
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KLHL6 NFAM1 FCER1A CD86 SNX10 GNAO1 CLNK HCK HCLS1	1.31e-07	200	180	9	41a206350eff2a196ccc1a36a9636a87c74f6962
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDE1C DOCK11 HOPX ANO5 PITPNC1 GRM1 GNA14 CDH9	3.13e-07	161	180	8	bf70be1de418615b5442ec684552551edaf1f072
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR MYH6 STAG1 TRPM7 PEG3 CPED1 HMCN1 PCDH7	6.16e-07	176	180	8	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MPP3 CP BMP1 TENM4 SHANK2 SYNE2 C5 CLNK	7.00e-07	179	180	8	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C ANO5 APOB GRM1 CSMD3 FAT1 TENM4 HMCN1	8.62e-07	184	180	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C ANO5 APOB GRM1 CSMD3 FAT1 TENM4 HMCN1	8.62e-07	184	180	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	DOCK11 CUBN SERPINA1 FAT1 TINAG SYNE2 CDH2 CDH9	8.62e-07	184	180	8	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C ANO5 APOB GRM1 CSMD3 FAT1 TENM4 HMCN1	8.62e-07	184	180	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MPP3 AHI1 CP BMP1 TENM4 SHANK2 C5 CLNK	9.35e-07	186	180	8	e83718fabb057100835d3357df407f283d23fe16
ToppCell	NS-moderate-d_0-4-Myeloid-Non-resident_Macrophage\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ADAMTS2 NFAM1 CEMIP SERPINA1 CD86 DNAH17 SNX10 HCK	9.73e-07	187	180	8	fcc32dbc9c5ae6176f154715a3e73aa32d78ad64
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH11 SYNDIG1 CPED1 RGN FAT1 TENM4 ARHGAP28 GNAO1	9.73e-07	187	180	8	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ\|B_lymphocytes / Location, Cell class and cell subclass	KLHL6 HOPX PITPNC1 ARHGDIB IGF2BP3 UCP2 SYNE2 HCLS1	1.10e-06	190	180	8	c5c80a6b9087821a2e07250fa90bcd3505f103b6
ToppCell	droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH6 PDE1C NRAP HOPX CASQ2 COQ8A CDH2 PCDH7	1.14e-06	191	180	8	97fb4232417a39801e87725755fd16a57c250209
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	MPP3 MYH6 PDE1C TRPM7 ANO5 DST CDH2 PCDH7	1.14e-06	191	180	8	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HOPX CP TTC6 PLEKHG4B FAT1 SHANK2 GNA14 KIAA1217	1.14e-06	191	180	8	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH6 PDE1C NRAP HOPX CASQ2 COQ8A CDH2 PCDH7	1.14e-06	191	180	8	64070a309d7e3f6001272409ab9ce206d0e7d73f
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNDIG1 ARHGDIB SERPINA1 ADRB2 CD86 UCP2 HCK HCLS1	1.19e-06	192	180	8	314d94d676d13f4ca0eea8ba222c7eb00946849c
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SPTBN1 TEX15 FAS CSMD3 GNA14 ARHGAP28 GNAO1 PCDH7	1.28e-06	194	180	8	99577a5a631e607b5abe7a1b0d8d6a5eabe50196
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL6 IQGAP2 ARRDC5 ARHGDIB CD86 TNK2 HCK HCLS1	1.28e-06	194	180	8	4dfc890bacf133cfb6ec7c8b73f084f2491cf78e
ToppCell	(2)_Mono_macro\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	IQGAP2 SERPINA1 CD86 UCP2 SNX10 GNAO1 HCK HCLS1	1.28e-06	194	180	8	7c05525614ee8cdfcbf22cce9146a8e73af7d14e
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SPTBN1 TEX15 FAS CSMD3 GNA14 ARHGAP28 GNAO1 PCDH7	1.33e-06	195	180	8	70387a62f121f8c374dba1aca9ab65cfed6a0b10
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|lung / Disease (COVID-19 only), tissue and cell type	KLHL6 IQGAP2 DYSF NFAM1 CD86 SNX10 HCK HCLS1	1.33e-06	195	180	8	148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	KLHL6 NFAM1 ARHGDIB CD86 UCP2 SNX10 HCK HCLS1	1.33e-06	195	180	8	799992721369357484300fe218aff075154c3148
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	KLHL6 NFAM1 ARHGDIB CD86 UCP2 SNX10 HCK HCLS1	1.38e-06	196	180	8	3fd5567ea14193181929134c377e8a38fb4f47fd
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	CFAP47 AHI1-DT SPTBN1 SHANK2 GNA14 KIAA1217 SYNE2 CTTN	1.38e-06	196	180	8	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	KLHL6 NFAM1 ARHGDIB SERPINA1 CD86 SNX10 HCK HCLS1	1.38e-06	196	180	8	b904f3a6d6a93e149f5a1b34b6adad5c7894754d
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	CFAP47 AHI1-DT SPTBN1 SHANK2 GNA14 KIAA1217 SYNE2 CTTN	1.38e-06	196	180	8	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	PDE1C SPTBN1 DYSF PTPRB GNA14 ADAMTS6 KIAA1217 SYNE2	1.44e-06	197	180	8	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	Children_(3_yrs)-Immune\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KLHL6 IQGAP2 DOCK11 FRMD4A CD86 SNX10 HCK HCLS1	1.44e-06	197	180	8	f18807124b91310fcd84238484a80ecdba684679
ToppCell	background-Kupffer_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	KLHL6 DOCK11 NFAM1 FRMD4A CD86 UCP2 HCK HCLS1	1.44e-06	197	180	8	8b45c7ecc18d188abc8c172d9bf881c95617a46a
ToppCell	Adult-Immune\|Adult / Lineage, Cell type, age group and donor	KLHL6 IQGAP2 DOCK11 FRMD4A CD86 SNX10 HCK HCLS1	1.49e-06	198	180	8	9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CP TTC6 PLEKHG4B FAT1 SHANK2 GNA14 KIAA1217 SYNE2	1.49e-06	198	180	8	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NFAM1 CPED1 FCER1A CD86 SNX10 GNAO1 HCK HCLS1	1.49e-06	198	180	8	d73585a5587941483db8d9ddc2d68f7d852bbbc8
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MPP3 AHI1 CP TTC6 BMP1 FAT1 C5 CLNK	1.49e-06	198	180	8	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	distal-2-Hematologic\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IQGAP2 ARHGDIB SERPINA1 CD86 UCP2 SNX10 HCK HCLS1	1.55e-06	199	180	8	6eb7dc2e170da139f3fb80bed2076d5f7a06b4b2
ToppCell	Parenchymal-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KLHL6 IQGAP2 DOCK11 FRMD4A CD86 SNX10 HCK HCLS1	1.55e-06	199	180	8	7ee2805fd9143eba11bf6832267b62189683608b
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	PDE1C SLC26A3 SPTBN1 PTPRB GNA14 ADAMTS6 KIAA1217 SYNE2	1.55e-06	199	180	8	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	Lung_Parenchyma-Severe-Myeloid-cDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ARHGDIB FCER1A CD86 UCP2 GNAO1 CLNK HCK HCLS1	1.61e-06	200	180	8	9744d53915c8dc9d5e011cbbb0ac7db44c615ce7
ToppCell	Parenchyma_COVID-19-Immune-TX-DCs\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	ARHGDIB FCER1A CD86 UCP2 GNAO1 CLNK HCK HCLS1	1.61e-06	200	180	8	6237e4b46b196e1d1610b2edc60af4716a6fed25
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FCER1A CD86 SNX10 SIGLEC11 GNAO1 CLNK HCK HCLS1	1.61e-06	200	180	8	f19b729b03b5f225b9ed676f0ac31071a4354da3
ToppCell	Lung_Parenchyma-Severe-Myeloid-cDC-DCs-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARHGDIB FCER1A CD86 UCP2 GNAO1 CLNK HCK HCLS1	1.61e-06	200	180	8	b52f7534a5ff504dccc002ebc30836a87e43c123
ToppCell	Lung_Parenchyma-Severe-Myeloid-cDC-DCs\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ARHGDIB FCER1A CD86 UCP2 GNAO1 CLNK HCK HCLS1	1.61e-06	200	180	8	cb0ba75be8fb2ec47474559911df80d085c4dbc8
ToppCell	10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT\|GI_small-bowel / Manually curated celltypes from each tissue	ABCB5 CP CFB SERPINA1 ADRB2 GYS2 C9	2.22e-06	146	180	7	1cb2e157222631e8915d89b255a843d16d7d99cc
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RBM44 IQGAP2 NAA50 NFAM1 GYS2 DNAH17 HCLS1	3.59e-06	157	180	7	eea53cf8d8a607264e1ee00b7a97c94bcf2ac80d
ToppCell	facs-Marrow-B-cells-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBOAT1 CSMD3 FCER1A DNAH17 TNK2 ZNF512 ARMH3	5.18e-06	166	180	7	13027ae342994db4540e64eb910df1f42b160931
ToppCell	facs-Marrow-B-cells-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBOAT1 CSMD3 FCER1A DNAH17 TNK2 ZNF512 ARMH3	5.18e-06	166	180	7	b21e45bd43f26149b9cd6e45c19241c82d54fb2f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CMBL SLC26A3 CUBN CSMD3 TTC6 IGF2BP3 KCNU1	5.39e-06	167	180	7	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Myeloid\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFAM1 ARHGDIB UCP2 TPX2 HCK CDCA7L HCLS1	6.06e-06	170	180	7	d582087a983fe20d811d92f0de0458f3cfd71d2b
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Myeloid-macrophage\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFAM1 ARHGDIB UCP2 TPX2 HCK CDCA7L HCLS1	6.06e-06	170	180	7	dfbe7ba11b867a4e10fa915f282a2e5cb2f5fb8c
ToppCell	356C-Myeloid-Dendritic-cDC1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MPP3 PDE1C PLEKHG4B GNAO1 CLNK CDH2 ZNF662	6.30e-06	171	180	7	3d60e7ecf25e4b781ba2387671b2aad247fb75ff
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Myeloid-myeloid_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQGAP2 NFAM1 ARHGDIB CD86 UCP2 HCK HCLS1	6.54e-06	172	180	7	6b01448443cf8392ed8248ff452b80c31240b85d
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Myeloid\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQGAP2 NFAM1 ARHGDIB CD86 UCP2 HCK HCLS1	6.54e-06	172	180	7	0c0ae2da3cba6022403434567800f16e61a34a2b
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Myeloid-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQGAP2 NFAM1 ARHGDIB CD86 UCP2 HCK HCLS1	6.54e-06	172	180	7	d80c207f3489be2da2f40f47a7835cb73c949c3e
ToppCell	Bac-SEP-Myeloid-cDC1\|Bac-SEP / Disease, Lineage and Cell Type	MPP3 B3GNTL1 PLEKHG4B DST GNAO1 CLNK CDH2	6.79e-06	173	180	7	f88269327441858ddb8c49b9dd619b76fd53b1da
ToppCell	COVID-19-kidney-PCT-S3-2\|kidney / Disease (COVID-19 only), tissue and cell type	CP APOB SERPINA1 GYS2 C5 C6 C9	7.06e-06	174	180	7	5aa2fb631505600f37d2b87b02def7be139dc262
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE1C MYH13 COL6A5 CSMD3 CEMIP ARHGAP28 PCDH7	7.06e-06	174	180	7	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(II)\|lymph-node_spleen / Manually curated celltypes from each tissue	KLHL6 HOPX IGF2BP3 SHANK2 CD86 UCP2 SYNE2	7.60e-06	176	180	7	5788dd5b23ebb52f19d3b5bdbcfe25dee349cf77
ToppCell	COVID-19-kidney-PCT-S3-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CP APOB SERPINA1 GYS2 C5 C6 C9	7.60e-06	176	180	7	b6497324e3e52f514ce556a3fa0c3011c45dcc7b
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH6 NRAP CASQ2 SYNDIG1 CPED1 CDH2 PCDH7	7.60e-06	176	180	7	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	B3GNTL1 DYSF TENM4 ZNF846 SIGLEC11 CLNK HCK	7.89e-06	177	180	7	345cebc19f93970a9a46be139208b300081f5493
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR STAG1 PTPRB CCDC82 SYNE2 DIAPH1 UBXN2A	8.18e-06	178	180	7	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue\|TCGA-Liver / Sample_Type by Project: Shred V9	CPED1 GNA14 GYS2 ZFP1 SIGLEC11 GNAO1 C9	8.49e-06	179	180	7	17ba1eedb6ebf039d3b11d099351d0ac6363c8d1
ToppCell	TCGA-Liver-Solid_Tissue_Normal\|TCGA-Liver / Sample_Type by Project: Shred V9	CPED1 GNA14 GYS2 ZFP1 SIGLEC11 GNAO1 C9	8.49e-06	179	180	7	7046f0a426e45fe1b41a25721ee1e33f6fc7f9e3
ToppCell	TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue-2\|TCGA-Liver / Sample_Type by Project: Shred V9	CPED1 GNA14 GYS2 ZFP1 SIGLEC11 GNAO1 C9	8.49e-06	179	180	7	a20bb3ace5be10c5aef330e9268c0ba55f8fee23
ToppCell	TCGA-Liver-Solid_Tissue_Normal-Liver\|TCGA-Liver / Sample_Type by Project: Shred V9	CPED1 GNA14 GYS2 ZFP1 SIGLEC11 GNAO1 C9	8.49e-06	179	180	7	0e22e840f43ca81a7543dcf33ec17a741cdf7f37
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 CUBN FAT1 TINAG CDH2 CDH9 HSPB8	8.49e-06	179	180	7	58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC1\|lymph-node_spleen / Manually curated celltypes from each tissue	PDE1C SRC PLEKHG4B DST CLNK CDH2 HCK	8.80e-06	180	180	7	a7db1f00566c9acab8b239cbf2e053fb3f2f6a0d
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTBN1 PITPNC1 PTPRB GNA14 KIAA1217 SYNE2 PXN	8.80e-06	180	180	7	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CUBN FAT1 TINAG SHANK2 SYNE2 CDH2 CDH9	8.80e-06	180	180	7	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF585A POLR1A SRC PEX1 TERT FRMD4A SNX10	8.80e-06	180	180	7	be10fe5bf7c3a671c42704ce7dd8226ab6896794
ToppCell	COVID-19-kidney-tDL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CMBL CUBN FAT1 TINAG SHANK2 CDH2 CDH9	8.80e-06	180	180	7	864c895b5eaedefae86f5829fa344f7b686fb59f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF585A POLR1A SRC PEX1 TERT FRMD4A SNX10	8.80e-06	180	180	7	3b747a517ce75ef2ff09011c037dad7b01ed3e03
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	PDE1C SPTBN1 PTPRB GNA14 ADAMTS6 KIAA1217 SYNE2	9.13e-06	181	180	7	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MPP3 CP BMP1 TENM4 SHANK2 C5 CLNK	9.13e-06	181	180	7	0513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH11 SYNDIG1 CPED1 FAT1 ADAMTS6 ARHGAP28 PCDH7	9.13e-06	181	180	7	25915e2500430a902db37d79a749ce2990b69810
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HOPX CP TTC6 PLEKHG4B FAT1 SHANK2 KIAA1217	9.46e-06	182	180	7	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	COVID-19-Heart-CM_4\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MPP3 NRAP TDRD9 CASQ2 ANO5 ZNF728 CDH2	9.80e-06	183	180	7	2902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCell	facs-Lung-Endomucin-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KDELR2 SPTBN1 PITPNC1 FAS ADRB2 PTPRB HMCN1	9.80e-06	183	180	7	1e51aeaa8fc9383b424cce128a890e07cb6025f3
ToppCell	wk_15-18-Hematologic-Myeloid-CXCL9+_Mac\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	SERPINA1 CD86 RHEBL1 UCP2 SNX10 HCK HCLS1	9.80e-06	183	180	7	99a36e9c74346b619b3b87d8d6bbf9b4b797c821
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MPP3 CP BMP1 TENM4 SHANK2 C5 CLNK	9.80e-06	183	180	7	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL6 ARRDC5 CD86 GNAO1 CLNK HCK HCLS1	1.02e-05	184	180	7	4f4aeef3b821a003e857fe4a195124d44b2d7479
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MPP3 CP BMP1 TENM4 SHANK2 C5 CLNK	1.02e-05	184	180	7	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	HOPX CP TTC6 FAT1 SHANK2 GNA14 KIAA1217	1.05e-05	185	180	7	673f0c688ae6984bc8027df2da335787924f4137
Computational	Genes in the cancer module 58.	CFB C5 C6 C9	5.63e-05	21	111	4	MODULE_58
Computational	Complement.	CFB C5 C6 C9	8.20e-05	23	111	4	MODULE_130
Disease	aplastic anemia (is_marker_for)	FAS TERT CD86	1.71e-05	9	176	3	DOID:12449 (is_marker_for)
Disease	Age related macular degeneration	CFB HMCN1 C9 PARP12	2.97e-05	30	176	4	C0242383
Disease	beta thalassemia (is_marker_for)	APOB TERT CFB	3.32e-05	11	176	3	DOID:12241 (is_marker_for)
Disease	level of UL16-binding protein 6 in blood serum	ULBP2 RAET1L	3.54e-05	2	176	2	OBA_2043185
Disease	Complement deficiency disease	CFB C5 C6 C9	4.37e-05	33	176	4	C0272242
Disease	distal myopathy (implicated_via_orthology)	MYH6 MYH13 DYSF	4.41e-05	12	176	3	DOID:11720 (implicated_via_orthology)
Disease	type 1 diabetes mellitus (is_marker_for)	CP APOB FAS CFB CD86	7.22e-05	72	176	5	DOID:9744 (is_marker_for)
Disease	kidney disease (implicated_via_orthology)	SRC CUBN ADRB2 HCK	1.04e-04	41	176	4	DOID:557 (implicated_via_orthology)
Disease	Age-related macular degeneration	CFB HMCN1 C9	1.59e-04	18	176	3	cv:C0242383
Disease	Male Germ Cell Tumor	FAS DICER1	2.11e-04	4	176	2	C3496549
Disease	factor VIII deficiency (is_marker_for)	CFB C5	2.11e-04	4	176	2	DOID:12134 (is_marker_for)
Disease	inflammatory biomarker measurement, YKL40 measurement	MYH11 NDE1 PITPNC1 ZNF662	2.46e-04	51	176	4	EFO_0004869, EFO_0004872
Disease	RS-6-hydroxywarfarin measurement	PLEKHG4B SHANK2 GNA14 CTTN PCDH7 TRAPPC9	3.47e-04	155	176	6	EFO_0803328
Disease	congestive heart failure (biomarker_via_orthology)	MYH6 CASQ2 FAS ADRB2 UCP2	4.64e-04	107	176	5	DOID:6000 (biomarker_via_orthology)
Disease	Limb-girdle muscular dystrophy	MYH6 ANO5 DYSF	4.90e-04	26	176	3	cv:C0686353
Disease	Myasthenia Gravis	FAS CFB	5.22e-04	6	176	2	C0026896
Disease	Myasthenia Gravis, Ocular	FAS CFB	5.22e-04	6	176	2	C0751340
Disease	Myasthenia Gravis, Generalized	FAS CFB	5.22e-04	6	176	2	C0751339
Disease	Shwachman-Diamond syndrome (implicated_via_orthology)	EFL1 SERPINI2	7.28e-04	7	176	2	DOID:0060479 (implicated_via_orthology)
Disease	limb-girdle muscular dystrophy (implicated_via_orthology)	DYSF MYOF	7.28e-04	7	176	2	DOID:11724 (implicated_via_orthology)
Disease	Ventricular Dysfunction, Left	FAS ADRB2 VDAC1	7.52e-04	30	176	3	C0242698
Disease	PR interval	MYH11 ARRDC5 ABCB5 SPTBN1 DYSF FAT1 COQ8A SYNE2 MKLN1 HSPB8	8.21e-04	495	176	10	EFO_0004462
Disease	coronary artery disease	KDELR2 IFT140 PDE1C MYH11 STAG1 TRPM7 ZNF652 HEMGN APOB CFB BMP1 SERPINA1 KIAA1217 C5 GNAO1 ABCC10 PARP12	8.34e-04	1194	176	17	EFO_0001645
Disease	granulocyte count	CCDC125 AHI1 EML6 TERT MED24 ADRB2 COQ8A	8.65e-04	254	176	7	EFO_0007987
Disease	Acute Myeloid Leukemia, M1	MYH11 ANXA6 NUP98 FAS TERT	9.39e-04	125	176	5	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	MYH11 ANXA6 NUP98 FAS TERT	9.39e-04	125	176	5	C1879321
Disease	PH and SEC7 domain-containing protein 1 measurement	CFB SERPINA1	9.67e-04	8	176	2	EFO_0803302
Disease	Autistic Disorder	AHI1 FMR1 CP CSMD3 ADRB2 SHANK2 CDH9	1.01e-03	261	176	7	C0004352
Disease	Colorectal Carcinoma	AMPD1 TRPM7 ABCB5 PEG3 SRC APOB CUBN GRM1 CSMD3 FAT1 GUCY2C TPX2	1.09e-03	702	176	12	C0009402
Disease	acute lymphoblastic leukemia (is_marker_for)	FAS TERT CD86	1.09e-03	34	176	3	DOID:9952 (is_marker_for)
Disease	ulcerative colitis (biomarker_via_orthology)	FAS ADRB2	1.24e-03	9	176	2	DOID:8577 (biomarker_via_orthology)
Disease	abdominal fat cell number	PDE1C SPTBN1 IGF2BP3 KIAA1217 CDH9 CDCA7L	1.25e-03	198	176	6	EFO_0021534
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH6 MYH13 DICER1 ADRB2	1.36e-03	80	176	4	DOID:12930 (implicated_via_orthology)
Disease	electrocardiography	MYH6 MYH11 MBOAT1 SPTBN1 CASQ2 CEMIP MKLN1 GNAO1 CDH2 HCK	1.37e-03	530	176	10	EFO_0004327
Disease	Epilepsy, Cryptogenic	GRM1 STAMBP GNAO1 VDAC1	1.49e-03	82	176	4	C0086237
Disease	Awakening Epilepsy	GRM1 STAMBP GNAO1 VDAC1	1.49e-03	82	176	4	C0751111
Disease	Aura	GRM1 STAMBP GNAO1 VDAC1	1.49e-03	82	176	4	C0236018
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH6 MYH13	1.54e-03	10	176	2	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH6 MYH13	1.54e-03	10	176	2	DOID:0111596 (implicated_via_orthology)
Disease	familial hypercholesterolemia (is_implicated_in)	APOB ADRB2	1.54e-03	10	176	2	DOID:13810 (is_implicated_in)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH6 MYH13	1.54e-03	10	176	2	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH6 MYH13	1.54e-03	10	176	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH6 MYH13	1.54e-03	10	176	2	DOID:0111605 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH6 MYH13	1.54e-03	10	176	2	DOID:0111269 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH6 MYH13	1.54e-03	10	176	2	DOID:0110454 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH6 MYH13	1.54e-03	10	176	2	DOID:0080326 (implicated_via_orthology)
Disease	total blood protein measurement	STAG1 IQGAP2 DYSF TERT RGN SERPINA1 CD86 GNAO1 VDAC1	1.57e-03	449	176	9	EFO_0004536
Disease	Thyroid preparation use measurement	PDE1C AHI1-DT GNAO1 CLNK VDAC1 STK25	1.98e-03	217	176	6	EFO_0009933
Disease	progression free survival, urinary bladder cancer	IFT140 TENM4	2.24e-03	12	176	2	EFO_0004920, MONDO_0001187
Disease	myotonia congenita (implicated_via_orthology)	MYH6 MYH13	2.24e-03	12	176	2	DOID:2106 (implicated_via_orthology)
Disease	Myeloproliferative disease	GSKIP TERT	2.24e-03	12	176	2	C0027022
Disease	Thyroid carcinoma	TPR TERT DICER1	2.31e-03	44	176	3	C0549473
Disease	neutrophil count, basophil count	CCDC125 AHI1 EML6 TERT ADRB2 COQ8A	2.33e-03	224	176	6	EFO_0004833, EFO_0005090
Disease	bronchopulmonary dysplasia	CSMD3 ZNF728 TNK2	2.46e-03	45	176	3	MONDO_0019091
Disease	selective IgA deficiency disease	AHI1 FAS CD86	2.62e-03	46	176	3	EFO_1001929
Disease	velocity of sound measurement	SPTBN1 CPED1	2.64e-03	13	176	2	EFO_0005654
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH6 MYH13	2.64e-03	13	176	2	DOID:397 (implicated_via_orthology)
Disease	autoimmune thrombocytopenic purpura (is_marker_for)	FAS CD86	2.64e-03	13	176	2	DOID:8924 (is_marker_for)
Disease	IGF-1 measurement	KDELR2 IFT140 EPHA6 STAG1 ARRDC5 NUP98 MED24 SERPINA1 SYNE2	2.75e-03	488	176	9	EFO_0004627
Disease	Cardiomyopathy, Dilated	MYH6 FAS ADRB2	2.96e-03	48	176	3	C0007193
Disease	Autosomal recessive limb-girdle muscular dystrophy	ANO5 DYSF	3.07e-03	14	176	2	cv:C2931907
Disease	autosomal dominant polycystic kidney disease (is_marker_for)	CFB C9	3.07e-03	14	176	2	DOID:898 (is_marker_for)
Disease	cholesteryl ester 20:3 measurement	MYH11 NDE1 APOB	3.14e-03	49	176	3	EFO_0010347
Disease	acute myeloid leukemia (is_marker_for)	FAS TERT CD86	3.14e-03	49	176	3	DOID:9119 (is_marker_for)
Disease	mean platelet volume	MPP3 KDELR2 MYH11 IQGAP2 NDE1 DOCK11 SPTBN1 EML6 TERT CD86 GYS2 UCP2 SYNE2 DIAPH1	3.33e-03	1020	176	14	EFO_0004584
Disease	Cardiomyopathy, Familial Idiopathic	MYH6 FAS ADRB2	3.33e-03	50	176	3	C1449563
Disease	Tourette syndrome	EFL1 CSMD3 TENM4	3.33e-03	50	176	3	EFO_0004895
Disease	Liver Cirrhosis	TRPM7 CP RGN SERPINA1	3.42e-03	103	176	4	C0023890
Disease	distal arthrogryposis (implicated_via_orthology)	MYH6 MYH13	3.53e-03	15	176	2	DOID:0050646 (implicated_via_orthology)
Disease	Gastro-enteropancreatic neuroendocrine tumor	SERPINA1 CD86	3.53e-03	15	176	2	C2930967
Disease	Liver carcinoma	IQGAP2 CP TERT SERPINA1 IGF2BP3 GYS2 TPX2 GNAO1 C9	3.53e-03	507	176	9	C2239176
Disease	Fibrosis, Liver	TRPM7 CP RGN SERPINA1	3.66e-03	105	176	4	C0239946
Disease	melanoma	ABCB5 ECHDC1 CP CUBN TERT SDHD	3.84e-03	248	176	6	C0025202
Disease	Leukemia, Myelocytic, Acute	MYH11 ANXA6 NUP98 FAS TERT	3.88e-03	173	176	5	C0023467
Disease	pancreatic carcinoma	ARRDC5 APOB TERT MED24 DST	3.98e-03	174	176	5	EFO_0002618
Disease	sickle cell anemia (is_implicated_in)	APOB CFB	4.02e-03	16	176	2	DOID:10923 (is_implicated_in)
Disease	hepatocellular carcinoma (biomarker_via_orthology)	SRC FAS TERT RGN	4.05e-03	108	176	4	DOID:684 (biomarker_via_orthology)
Disease	pulse pressure measurement	EPC2 MYH6 MYH11 TRPM7 CASQ2 FAS DYSF FAM186B CFB TENM4 KIAA1217 MKLN1 GNAO1 ARMH3 TRAPPC9 ABCC10 STK25	4.14e-03	1392	176	17	EFO_0005763
Disease	urate measurement, bone density	B3GNTL1 MBOAT1 ABCB5 COL6A5 PAM16 MINPP1 CFB FSIP2 CEP83 DIAPH1	4.18e-03	619	176	10	EFO_0003923, EFO_0004531
Disease	treatment-resistant hypertension	POLR1A EML6 GNAO1 CLNK	4.18e-03	109	176	4	EFO_1002006
Disease	Epilepsy	GRM1 STAMBP GNAO1 VDAC1	4.18e-03	109	176	4	C0014544
Disease	coronary artery disease, factor VII measurement	STAG1 ZNF652 APOB NFS1	4.46e-03	111	176	4	EFO_0001645, EFO_0004619
Disease	retinopathy	SRC TENM4	4.54e-03	17	176	2	EFO_0003839
Disease	Antibody Deficiency Syndrome	C5 C9	4.54e-03	17	176	2	C0003257
Disease	Lipidemias	APOB ADRB2	4.54e-03	17	176	2	C1706412
Disease	Hyperlipidemia	APOB ADRB2	4.54e-03	17	176	2	C0020473
Disease	cholesteryl esters to total lipids in large VLDL percentage	MPP3 APOB SERPINA1	4.59e-03	56	176	3	EFO_0022250
Disease	factor VIII measurement, coronary artery disease	STAG1 ZNF652 APOB SERPINA1	4.75e-03	113	176	4	EFO_0001645, EFO_0004630
Disease	free cholesterol to total lipids in very large VLDL percentage	MPP3 APOB SERPINA1	5.31e-03	59	176	3	EFO_0022289
Disease	asthma (biomarker_via_orthology)	FAS SERPINA1 CD86	5.31e-03	59	176	3	DOID:2841 (biomarker_via_orthology)
Disease	Intellectual Disability	AHI1 FMR1 STAG1 PTPN23 SHANK2 DIAPH1 ZBTB11 CDH2	5.57e-03	447	176	8	C3714756
Disease	polycystic kidney disease (biomarker_via_orthology)	CFB C9	5.66e-03	19	176	2	DOID:0080322 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
VGYKTDEFQLHTNVN	VDAC1	171	P21796
NKSDIKQYDFHSSDE	EPC2	361	Q52LR7
VNAKFEDSGEYKCQH	FCER1A	81	P12319
GEQSGYHVEQEKENK	ADRB2	361	P07550
EKNEEVFNYGNHLKE	ANKRD30B	1346	Q9BXX2
AEEGEKVNKHIDYSF	ANO5	11	Q75V66
NSKRESKIEHGNFTY	CSMD3	2941	Q7Z407
LDTAKKHGYEVVDTF	CPED1	921	A4D0V7
VDEHTGQYVKKDDSG	AHI1	371	Q8N157
GNNDKTTLKHDAEIY	ABCB5	721	Q2M3G0
EDVKKLYHSEAFTVN	SERPINA1	156	P01009
HFGEKADSENQARKY	EFL1	1076	Q7Z2Z2
YNHLDKFNIDKEAGE	GYS2	221	P54840
NRQYKDKEEEHQSGF	ARMH3	256	Q5T2E6
GISHEEKVKFLGDNY	AMPD1	691	P23109
VKEAQKYGEDSQKSH	AHI1-DT	11	P0C7V0
TFLKSEFEHQKEEYA	CEP83	156	Q9Y592
SLGHKDKDQEDYFQK	FAM186B	436	Q8IYM0
RKKLNEYENGEFSFH	ANKRD26	1371	Q9UPS8
NEVYLGKEKFDSVHS	CD86	66	P42081
VTDYVHGDALQKAAK	SDHD	111	O14521
EKEETAGSYDSRNKH	DIAPH1	201	O60610
HLISGFENFEKKINY	DICER1	1661	Q9UPY3
ADVKTKDLYSHAQFG	BMP1	866	P13497
KLFQTEHGEYFNVSL	CEMIP	301	Q8WUJ3
DSVVQFHGKEHVQKY	ADAMTS2	276	O95450
KNTTEDSKHFSYENG	ADAMTS6	171	Q9UKP5
SHFEYVKNEDLEKIG	TNK2	36	Q07912
FIEKYDKSLHQAIEG	ANXA6	641	P08133
KLVAFNKHEDGYAAV	IGDCC4	716	Q8TDY8
QKQLLEDYGESHFTV	NUP93	441	Q8N1F7
NTYSKIVTLGKDEFH	RHEBL1	41	Q8TAI7
DVYGQEESLHVSKFQ	RBM44	251	Q6ZP01
AKIFGLFHDQKNESY	GUCY2C	746	P25092
SGKSVAHEDIKYEQA	PTPN23	101	Q9H3S7
HANGRQKDVDKEFYL	CP	566	P00450
EINYEDHKLKSGTNT	CFB	341	P00751
DNYQIKVVASDHGEK	FAT1	2881	Q14517
ESKKEGAVALHVYQA	ABCC10	861	Q5T3U5
VLDHFEKQYSKELGD	NSUN3	21	Q9H649
TGDFDHYEVTIKNKN	PTPRB	756	P23467
KVSHFSKYGLQDSDE	NUP98	876	P52948
KNEVYISGGKETQHD	KLHL6	376	Q8WZ60
KVYFHTDAAQAVGKI	NFS1	226	Q9Y697
SLQSDVNYKKGFEHS	NRAP	1096	Q86VF7
HGFYEEEVKKTLQQF	ECHDC1	36	Q9NTX5
HNDKYISNTSGEDEK	DST	2311	Q03001
DKTGTHLKYFSQKQD	DST	6656	Q03001
ADYVHKTKTFPVEDN	ARRDC5	86	A6NEK1
DGYVEVSGKHEEKQQ	HSPB8	116	Q9UJY1
YNHFKGASTRAEDTK	FSIP2	2896	Q5CZC0
EKDGTFDNIYLHVQI	NAA50	101	Q9GZZ1
DNDEGLKIAAKHYQF	PDCD6IP	141	Q8WUM4
TEGDQNKKKYFLHTS	PCDH7	476	O60245
SFVEALEVGYSKHKN	PDE1C	211	Q14123
GEKVTHTGQVYDDKD	NDUFS6	36	O75380
NKRFNHEDYGLSITK	FMO4	261	P31512
NSVIHETEYKRNFKG	MDM1	226	Q8TC05
KFDLVYHNENGAEVV	COIL	526	P38432
EQHLDKDKVYGVADS	KCNU1	936	A8MYU2
ESGKQQDVRFHSKYF	CDCA7L	51	Q96GN5
ILEYNFNKVDKHPDS	HOPX	16	Q9BPY8
ENDQVVVKITGHFYA	IGF2BP3	531	O00425
KIYDQEKSHGEESQG	PEG3	1051	Q9GZU2
QDPKAHQEDAKDAYT	HEMGN	436	Q9BXL5
LELKSVKFNDAGEYH	HMCN1	576	Q96RW7
SDYNQIEETLGFKIH	HMCN1	5066	Q96RW7
TLKFQAGKHNYELDF	PARP12	426	Q9H0J9
AGKHNYELDFKAFVQ	PARP12	431	Q9H0J9
VGEEEHVYSFPNKQK	PXN	111	P49023
ISDHSNEGQGFKIKY	CUBN	2196	O60494
DQEGHYSVKAQFKTS	FRMD4A	856	Q9P2Q2
VKVIDFGSSCYEHQK	DYRK4	246	Q9NR20
KNQSFYRKHFDTEET	GUCD1	96	Q96NT3
KVVGYAFDQVDDHLQ	GSKIP	86	Q9P0R6
GSTYEEETNKIKHRN	CCDC82	106	Q8N4S0
KLKSFDYHQFVDETN	APOB	2426	P04114
SNGAFYKAFVKDVHE	FMR1	11	Q06787
TFHIYGEDQDAVKKA	FMR1	261	Q06787
FSTLQELVDHYKKGN	HCK	216	P08631
GEERNEASFQYSKHK	CCDC125	66	Q86Z20
KEDQVEYHEGLKSNF	DOCK11	2006	Q5JSL3
KTDFYKDLTSLGHNE	C6	251	P13671
YEEVSKCENTKVFHG	DNAH17	1046	Q9UFH2
TYHNKSFFTDDDKQD	ARHGDIB	171	P52566
VFVLDHSGSIKKQYQ	COL6A5	816	A8TX70
VDQLFTDYQIKDGHV	C5	1446	P01031
GKVQGQDKHEEYFAE	COQ8A	56	Q8NI60
NNFKDYIAFIEGKHI	MBOAT1	201	Q6ZNC8
DQGFLEKEFYHKTNI	CSAG2	16	Q9Y5P2
YHEPVSSDKVTQKQF	CASQ2	56	O14958
KYDFNEKDEFRHTET	FAM172BP	21	A6NC97
SKDTGKYLAVASHDN	EML6	1091	Q6ZMW3
NAKRYFEAVQGSKEH	ERCC6L2	671	Q5T890
KFLDGVQEVAYIHSN	ERCC6L2	1121	Q5T890
KFKATYDGNHDTFRV	KDELR1	81	P24390
AHSDKIYSNAGEKSF	GRM1	256	Q13255
TQYVGKLHTDQDKGD	CDH9	71	Q9ULB4
KYEQFLSLEEGTKAH	CFAP47	1516	Q6ZTR5
GTKAHYFFEKVVNAA	CFAP47	1526	Q6ZTR5
GFEEHKQKTDVHYRS	DYSF	1846	O75923
KFKATYDGNHDTFRV	KDELR2	81	P33947
DGTVHYVDEKGKTTQ	IFT140	211	Q96RY7
ENTFSKADAEYKKLH	PEX1	186	O43933
SSEHAKFLIYAQDKE	CDH2	96	P19022
TKGEKNFRTEHYEEQ	C9	206	P02748
ESDESHGIKFKPNQY	EPHA6	131	Q9UF33
SHEKEGVEYHFVSKQ	MPP3	426	Q13368
DQNPDKEKVIYSHFT	GNA14	311	O95837
YKSVIQAVQKSEEGH	RTN3	896	O95197
GYSFKKDEIENSIVH	UTP6	76	Q9NYH9
VSDFDNAKGLNVKHY	SRC	191	P12931
IDLKFKEEVNHYSNE	POLR1A	861	O95602
EHADTEGNNKTVLKY	GTF3C6	81	Q969F1
KQLDTFEEEHGKYQA	SYNE2	3036	Q8WXH0
FYLSHETNKAVAKGD	SYNDIG1	201	Q9H7V2
YESKQSHEVLKGLFS	TDRD9	1091	Q8NDG6
VGFDYKGEVEKHTSQ	HCLS1	136	P14317
AIVQNITFGKYEKTH	MKLN1	66	Q9UL63
DVLYHAKSQKLGDSE	IQGAP2	496	Q13576
KVFTVSYFHEDLQGQ	NFAM1	76	Q8NET5
IHEDGFSGEDVKQYK	GNAO1	56	P09471
KGFTDHQTQKSDYLE	SLITRK3	941	O94933
KKYSHGDKDFTEDVN	MED24	321	O75448
HYNGKEFEKLLEEAQ	KIAA1217	981	Q5T5P2
SNQFLIYVHSKGEDV	SHPRH	146	Q149N8
AHVQESYTKDLDFKV	SGO2	931	Q562F6
HHVKKYFDQVDISNG	RGN	141	Q15493
YSTNAFEENHKKTGR	SLC26A3	16	P40879
LDIDHNQYKFGHTKV	MYH6	751	P13533
FGEVYKGIDNHTKEV	STK25	31	O00506
NFELAEYIKNHKETD	SHANK2	376	Q9UPX8
DVGHDEYSTQSLVKK	SPTBN1	771	Q01082
ENKIRKGFYCHEDSQ	B3GNTL1	296	Q67FW5
EHCKVEYQIKTFSGQ	CMBL	196	Q96DG6
KFDSVEDIIEHYKNF	CLNK	381	Q7Z7G1
DKTEFSIIHYAGKVD	MYH11	571	P35749
HLADIYAKSEKFQEA	PDCD11	1696	Q14690
QEKTHSGVEYSEYNK	ZFP1	146	Q6P2D0
EHAFESSQKYKEGKF	YPEL1	91	O60688
DSVKQFYTKGSEHAS	UCP2	101	P55851
EGEEYKAHKSVLSAN	ZBTB11	221	O95625
EKLYDSNHSGKVFNE	ZNF846	111	Q147U1
EYGHDEATKQAQKDF	TTC6	256	Q86TZ1
KNATALYHVEAFKTG	MINPP1	241	Q9UNW1
QAKGESHEYVTFSKL	RLF	646	Q13129
QEGKEYTDKAHFSSK	FAS	86	P25445
FDYQGKTEKHESQRD	CTTN	176	Q14247
KTEKHESQRDYSKGF	CTTN	181	Q14247
VGFEYQGKTEKHESQ	CTTN	211	Q14247
LQLHESQKDYKTGFG	CTTN	256	Q14247
GFDYKEKLAKHESQQ	CTTN	286	Q14247
GRHEKFKVESEQQYF	TPR	41	P12270
FSKTQKVEGSHDVYL	PLEKHG4B	1031	Q96PX9
KDILAKFQYENSHGS	ARHGAP28	666	Q9P2N2
SEEGNIEHAFILYNK	STAMBP	51	O95630
YKILHGFKDQVGEDN	TNPO2	861	O14787
DEDSKQNIFHFLYGK	SPDYE1	221	Q8NFV5
HEFYEETIVTKNGQK	TUSC2	61	O75896
SIHIETKYEDNKGSN	PITPNC1	106	Q9UKF7
VSHIKDFIEKYQGSQ	UBXN2A	196	P68543
TRENSYKSEEHGKAF	ZNF728	196	P0DKX0
AVQGQVDEKTFLHYD	RAET1G	51	Q6H3X3
TDTSFKNKLYDQHLG	MYH13	546	Q9UKX3
SHNGVLYIAETDEKK	TENM4	1476	Q6N022
IKNFHQYSVEGGKET	S100A14	26	Q9HCY8
GFTVKEQYLHGNKEF	SERPINI2	116	O75830
TLHKDGIEFAFKYQN	STAG1	976	Q8WVM7
AVQGQVDEKTFLHYD	RAET1L	51	Q5VY80
VDEKTFLHYDCGNKT	RAET1L	56	Q5VY80
EFKSASEKYNHAITE	SMCO3	201	A2RU48
GQTKYSVEEAIHKFA	SNX10	136	Q9Y5X0
NYEHLFKVNDKSVGG	PAM16	76	Q9Y3D7
KGFSYNSDLSIHEKI	ZNF585A	221	Q6P3V2
FKFNLDSVGKQHSEY	ZNF215	341	Q9UL58
YSSKKEINALAEHGD	ZZEF1	2411	O43149
FEKTQTGEKFYEHNK	ZNF510	216	Q9Y2H8
ESNKAGDYSHVKTLE	TRAPPC9	841	Q96Q05
NETTAKHVQEFYKLD	ZMYM1	1006	Q5SVZ6
QEYKESESHNSFGKS	TEX15	281	Q9BXT5
FKDGQHYEEGSVIKE	TINAG	121	Q9UJW2
AVQGQVDEKTFLHYD	ULBP2	51	Q9BZM5
VDEKTFLHYDCGNKT	ULBP2	56	Q9BZM5
FYHGANQELDLSTKV	ZNF652	36	Q9Y2D9
QKEFVSESGVKYHIN	ZNF512	446	Q96ME7
KGEEQELHYASLSFQ	SIGLEC11	636	Q96RL6
AETKHFLYSSGDKEQ	TERT	326	O14746
KYSDVKLGDHFNQAI	TRPM7	61	Q96QT4
YFNEKDDKFHSGSEE	TRPM7	1181	Q96QT4
TDKAQVHAVSFYSKG	nan	146	A6NL46
TYEQGVEKDKFLINH	TRBV20-1	71	A0A075B6N2
DFDQHQKTHNGEKVY	ZNF662	206	Q6ZS27
HPKNQEEYKEVNFTS	TPX2	271	Q9ULW0
ENKQKTDVHYRSLDG	MYOF	1826	Q9NZM1
ETIKEKFEVQHSEGY	NDE1	76	Q9NXR1